Cannell & Spears’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Cannell & Spears’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,809	Closed	-$30K	–	229
2022 Q3	$30K	Sell	11,809 -255	-2%	-$812	﹤0.01%	190
2022 Q2	$29K	Hold	12,064	–	–	﹤0.01%	209
2022 Q1	$50K	Hold	12,064	–	–	﹤0.01%	225
2021 Q4	$155K	Hold	12,064	–	–	0.01%	221
2021 Q3	$130K	Hold	12,064	–	–	0.01%	235
2021 Q2	$110K	Sell	12,064 -1,250	-9%	-$11.6K	0.01%	241
2021 Q1	$126K	Sell	13,314 -15,066	-53%	-$207K	0.01%	226
2020 Q4	$112K	Sell	28,380 -4,360	-13%	-$13.2K	0.01%	231
2020 Q3	$87K	Sell	32,740 -3,650	-10%	-$13.5K	0.01%	226
2020 Q2	$242K	Buy	36,390 +20,360	+127%	+$137K	0.03%	185
2020 Q1	$93K	Hold	16,030	–	–	0.01%	210
2019 Q4	$144K	Buy	+16,030	New	+$134K	0.02%	177

Other funds holding GRTS

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Cannell & Spears's GRTS Position: Q4 2022 in Review

Cannell & Spears sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2022, closing a stake of 11,809 shares — an estimated $30K sold.

Cannell & Spears first reported a position in GRTS in Q4 2019 and held it in 12 quarters. The position peaked at $242K in Q2 2020. 91 funds tracked by Wall St. Rank hold GRTS as of Q4 2022.

Cannell & Spears reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cannell & Spears sold 11,809 Gritstone bio, Inc. Common Stock shares in Q4 2022, an estimated $30K.
Cannell & Spears first reported a position in Gritstone bio, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
Cannell & Spears's Gritstone bio, Inc. Common Stock position peaked at $242K in Q2 2020.
91 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2022.

Based on Cannell & Spears's 13F filing for Q4 2022, filed 13 Feb 2023.